Overview
- Huawei previewed the HUAWEI WATCH D3 at the European Society of Cardiology Congress on Monday, said it holds CE MDR certification for single, ambulatory and pre/post‑exercise blood pressure measurements, and set a global launch event for September 2 in Munich.
- Huawei describes the Watch D3 as the next generation of its wrist ambulatory blood pressure recorders that uses an inflatable micro‑pump cuff in the strap to take readings and that it can measure during elevated heart rates and around exercise.
- The company markets the device as thinner and lighter than prior models with a rectangular display, a digital crown and side button, three colourways, and broader health features such as SpO2, sleep, emotional‑wellbeing tracking and a Health Glance summary.
- Huawei’s materials and reporters note CE MDR certification but also caution that Health Glance data are for reference and should not be used for diagnosis, and independent clinical or third‑party validation beyond the certification scope has not been published.
- Huawei will unveil the Watch D3 alongside new FreeBuds Neo at the September 2 event, a move that aims to push medical‑grade monitoring into everyday wearables and that will prompt scrutiny from clinicians, regulators and consumers for real‑world accuracy and availability.